Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,489 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06906237 | Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study(ScarABEO) | recruiting | — | 250 | Istituto Oncologico Veneto IRCCSOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07494201 | MIMICC Study in Patients With Colorectal Cancer(MIMICC) | recruiting | N/A | 2,500 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 27, 2026 |
| clinicaltrials |
| NCT07496242 | Immunological Phenotype of Desmoid-fibromatosis-affected Patients. | recruiting | — | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 2 | Mar 27, 2026 | clinicaltrials |
| NCT04383119 | Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma(ISG-ARTICLE) | recruiting | Phase 2 | 100 | Italian Sarcoma GroupNETWORK | 1 | Mar 25, 2026 | clinicaltrials |
| NCT06093672 | Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera(GIV-IN-PV) | recruiting | Phase 3 | 220 | ItalfarmacoINDUSTRY | 16 | Mar 25, 2026 | clinicaltrials |
| NCT06630806 | A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma | recruiting | Phase 1 | 87 | SanofiINDUSTRY | 7 | Mar 25, 2026 | clinicaltrials |
| NCT06932562 | A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant | recruiting | Phase 3 | 1,000 | European Myeloma Network B.V.NETWORK | 18 | Mar 25, 2026 | clinicaltrials |
| NCT07368582 | Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )(REWORI) | recruiting | — | 249 | Associazione Italiana Ematologia Oncologia PediatricaOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT04988555 | A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) | recruiting | Phase 1 / Phase 2 | 606 | Sumitomo Pharma America, Inc.INDUSTRY | 12 | Mar 24, 2026 | clinicaltrials |
| NCT06344208 | Predicting Toxicity in Elderly Patients With Head and Neck Cancer(PREtoxEL) | recruiting | — | 3 | European Institute of OncologyOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06703736 | Functional and Morphological Characterization of Multiple Osteochondromas Disorder(MAMBO) | recruiting | — | 60 | Istituto Ortopedico RizzoliOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06706557 | Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer(LEGO) | recruiting | — | 30 | European Institute of OncologyOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06706570 | PIK3CA Mutational Status Assessment | recruiting | — | 100 | European Institute of OncologyOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06762483 | Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,(L2-268) | recruiting | — | 80 | European Institute of OncologyOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07491536 | Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis(OZOMUC) | recruiting | N/A | 50 | University of PaviaOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07486947 | Unveiling Malnutrition and Metabolic Changes in Lung Cancer Patients: Setting the Basis for Precision Nutrition Models.(LISTENING) | recruiting | — | 180 | Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-HenaresOTHER | 2 | Mar 23, 2026 | clinicaltrials |
| NCT07479095 | Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma(KETO-FDG Lung) | recruiting | N/A | 30 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07485296 | Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC)(POST-BIO) | recruiting | Phase 2 | 45 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07486219 | Magnetic Resonance Imaging of the Lung: Oncological Applications | recruiting | — | 50 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT05853692 | Prevention of Oral Mucositis in Head and Neck Cancer.(OMHNC-1) | recruiting | N/A | 130 | Catholic University of the Sacred HeartOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07479277 | Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC(E-SEAL) | recruiting | N/A | 160 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT03590171 | International Study for Treatment of High Risk Childhood Relapsed ALL 2010 | recruiting | Phase 2 | 250 | Charite University, Berlin, GermanyOTHER | 15 | Mar 17, 2026 | clinicaltrials |
| NCT06868927 | Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform(TARGET-RCC) | recruiting | — | 50 | IRCCS San RaffaeleOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT07476495 | Insights on Dissemination of Lung Cancer(LUCID) | recruiting | — | 100 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT07473518 | Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy | recruiting | — | 2,550 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07469709 | A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks(PRO-ACTIVE) | recruiting | — | 850 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07469761 | MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care(MISTRAL) | recruiting | N/A | 120 | Augusto CaraceniOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07463989 | National Epidemiology of Cutaneous Lymphomas | recruiting | — | 1,000 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT04075305 | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study(MOMENTUM) | recruiting | — | 8,000 | UMC UtrechtOTHER | 9 | Mar 5, 2026 | clinicaltrials |
| NCT06952101 | A Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity(INTERPRETE) | recruiting | N/A | 200 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07356544 | Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC(HEROS) | recruiting | — | 50 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07453082 | A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors(BRIDGE) | recruiting | — | 100 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07447089 | EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study | recruiting | N/A | 25 | Università Cattolica di MilanoOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07448727 | Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT(PEMBRO-PET) | recruiting | — | 25 | University of Rome Tor VergataOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07448779 | Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment(GlycAL) | recruiting | — | 100 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07450612 | Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection(BEACON) | recruiting | — | 1,200 | San Raffaele UniversityOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06935344 | Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study(PROVE) | recruiting | — | 1,300 | Catholic University of the Sacred HeartOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07445412 | Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy(I-GROWtoh) | recruiting | — | 2,000 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07445438 | Feasibility of a Multi-omics Platform for Hematological Malignancies(FOCUS) | recruiting | N/A | 1,040 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07445984 | Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) | recruiting | N/A | 250 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT06876649 | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib | recruiting | Phase 4 | 787 | Eli Lilly and CompanyINDUSTRY | 8 | Mar 2, 2026 | clinicaltrials |
| NCT06876662 | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma | recruiting | Phase 4 | 279 | Eli Lilly and CompanyINDUSTRY | 8 | Mar 2, 2026 | clinicaltrials |
| NCT06532006 | A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer | recruiting | Phase 3 | 550 | Shanghai Henlius BiotechINDUSTRY | 17 | Feb 27, 2026 | clinicaltrials |
| NCT07432347 | Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches(DELIVER) | recruiting | — | 270 | Niguarda HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT02790983 | Primary Tumor Research and Outcomes Network(PTRON) | recruiting | — | 1,350 | AO Innovation Translation CenterOTHER | 9 | Feb 25, 2026 | clinicaltrials |
| NCT03016819 | Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)(APROMISS) | recruiting | Phase 3 | 325 | Advenchen Laboratories, LLCINDUSTRY | 5 | Feb 25, 2026 | clinicaltrials |
| NCT05549297 | Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) | recruiting | Phase 3 | 540 | Immunocore LtdINDUSTRY | 12 | Feb 25, 2026 | clinicaltrials |
| NCT06112314 | IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)(PRISM-MEL-301) | recruiting | Phase 3 | 680 | Immunocore LtdINDUSTRY | 26 | Feb 25, 2026 | clinicaltrials |
| NCT06336941 | "Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)(HOUSTON) | recruiting | N/A | 400 | University of PisaOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT07156136 | Study of IMC-P115C in Advanced PRAME-Positive Cancers | recruiting | Phase 1 | 140 | Immunocore LtdINDUSTRY | 4 | Feb 25, 2026 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials